Human medicines European public assessment report (EPAR): Kaftrio, ivacaftor,tezacaftor,elexacaftor, Date of authorisation: 21/08/2020, Revision: 31, Status: Authorised

Human medicines European public assessment report (EPAR): Eyluxvi, aflibercept, Date of authorisation: 15/09/2025, Status: Authorised

Human medicines European public assessment report (EPAR): Glivec, imatinib, Date of authorisation: 07/11/2001, Revision: 51, Status: Authorised

EVVet3 EVWeb Production - Release notes

List of eligible industry stakeholder organisations

Highlights – Fourth EMA-Vaccines Europe bilateral meeting

Faecal microbiota transplantation EU-IN Horizon Scanning Report

Human medicines European public assessment report (EPAR): Datopotamab deruxtecan Daiichi Sankyo, datopotamab deruxtecan, Status: Application withdrawn

Human medicines European public assessment report (EPAR): Slenyto, melatonin, Date of authorisation: 20/09/2018, Revision: 14, Status: Authorised

Agenda - PCWP/HCPWP and all eligible organisations meeting 2025